Company · CIK 1920092
Gelteq Ltd
| CIK | 1920092 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | C3 |
| Listed | GELS (Nasdaq) |
| First annual or quarterly report | 2024-11-15 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-288442 | 2025-07-01 | 2025-08-29 | 3 | |
| 333-280804 | 2024-07-15 | 2024-10-22 | 5 | |
| 333-267169 | 2022-08-30 | 2024-07-15 | 11 |
Filings
20| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-08-29 | EFFECTDeclared effective | 333-288442 | 9999999995-25-002789 |
| 2025-07-25 | F-1/AAmendment | 333-288442 | 0001213900-25-067491 |
| 2025-07-01 | F-1Registration filed | 333-288442 | 0001213900-25-059880 |
| 2024-10-22 | 424B4Final prospectus | 333-280804 | 0001213900-24-089716 |
| 2024-09-30 | EFFECTDeclared effective | 333-280804 | 9999999995-24-003030 |
| 2024-09-25 | F-1/AAmendment | 333-280804 | 0001213900-24-081526 |
| 2024-09-12 | F-1/AAmendment | 333-280804 | 0001213900-24-078217 |
| 2024-07-15 | F-1Registration filed | 333-280804 | 0001213900-24-061146 |
| 2024-07-15 | RWWithdrawn | 333-267169 | 0001213900-24-061145 |
| 2024-03-29 | EFFECTDeclared effective | 333-267169 | 9999999995-24-000777 |
| 2024-02-29 | F-1/AAmendment | 333-267169 | 0001213900-24-018165 |
| 2023-12-05 | F-1/AAmendment | 333-267169 | 0001213900-23-092895 |
| 2023-09-15 | F-1/AAmendment | 333-267169 | 0001213900-23-077069 |
| 2023-08-03 | F-1/AAmendment | 333-267169 | 0001213900-23-062710 |
| 2023-03-29 | F-1/AAmendment | 333-267169 | 0001213900-23-024025 |
| 2023-03-17 | F-1/AAmendment | 333-267169 | 0001213900-23-021111 |
| 2023-02-06 | F-1/AAmendment | 333-267169 | 0001213900-23-008078 |
| 2022-12-09 | F-1/AAmendment | 333-267169 | 0001213900-22-078682 |
| 2022-08-30 | F-1Registration filed | 333-267169 | 0001213900-22-052363 |
| 2022-03-31 | DRSDraft made public | 377-06110 | 0001213900-22-016627 |